{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-087828","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.842887+00:00","generated_at":"2026-05-31T10:20:52.609913+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NanoViricides extends President Diwan ($400k, 10k Series A shares) and CFO Vyas through June 2025","bullets":["President Anil Diwan's employment extended to June 30, 2025 at $400,000 base salary.","Diwan receives 10,204 Series A Preferred shares, vesting quarterly over the one-year term.","CFO Meeta Vyas extended on same general terms; new health insurance reimbursement up to $2,500/month.","Diwan eligible for six months' severance if terminated without cause, plus continued benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-087828","json":"https://secwatch.observer/filing/0001104659-24-087828.json","markdown":"https://secwatch.observer/filing/0001104659-24-087828.md","text":"https://secwatch.observer/filing/0001104659-24-087828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465924087828/0001104659-24-087828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465924087828/tm2421305d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:20:52.609913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}